OBJECTIVES: This study sought to investigate the immediate safety and feasibility of complete percutaneous access/closure of arteriotomy for device deployment compared to the surgical approach for transfemoral transcatheter aortic valve replacement (TAVR). BACKGROUND: The percutaneous approach for arterial access for device deployment in transfemoral TAVR is a potential alternative to the surgical approach. METHODS: In 274 patients who underwent transfemoral TAVR using Edward Sapien heart valve, 140 had a complete percutaneous approach using a "pre-closure" technique whereas 134 had surgical cut-down/repair for arterial access/closure of device deployment. Immediate vascular access/closure success, associated complications and clinical outcomes were compared. RESULTS: While overall acute success of access/closure and in-hospital access-related events were similar, significant isolated stenosis/dissection at the access site developed more frequently in the percutaneous group (7.1% vs. 0.7%, P = 0.007). Contrary, wound infections requiring prolonged antibiotics use or surgical debridement occurred more frequently in the surgical group (0.7% vs. 6.7%, P = 0.007). Although the rate of major vascular complications was not different, the surgical group developed more frequent minor bleeding (27.1% vs. 38.8%, P = 0.04) and underwent transfusion of packed red blood cells of ≤3 units (25.7% vs. 43.3%, P = 0.002). Median hospital stay was shorter in the percutaneous group (3 days vs. 4 days, P = 0.002). CONCLUSIONS: The percutaneous approach is a feasible access/closure method with a potential of lowering access site infection and bleeding, and shortening hospital stay, while maintaining similar rates of major vascular complications compared to the surgical approach.
OBJECTIVES: This study sought to investigate the immediate safety and feasibility of complete percutaneous access/closure of arteriotomy for device deployment compared to the surgical approach for transfemoral transcatheter aortic valve replacement (TAVR). BACKGROUND: The percutaneous approach for arterial access for device deployment in transfemoral TAVR is a potential alternative to the surgical approach. METHODS: In 274 patients who underwent transfemoral TAVR using Edward Sapien heart valve, 140 had a complete percutaneous approach using a "pre-closure" technique whereas 134 had surgical cut-down/repair for arterial access/closure of device deployment. Immediate vascular access/closure success, associated complications and clinical outcomes were compared. RESULTS: While overall acute success of access/closure and in-hospital access-related events were similar, significant isolated stenosis/dissection at the access site developed more frequently in the percutaneous group (7.1% vs. 0.7%, P = 0.007). Contrary, wound infections requiring prolonged antibiotics use or surgical debridement occurred more frequently in the surgical group (0.7% vs. 6.7%, P = 0.007). Although the rate of major vascular complications was not different, the surgical group developed more frequent minor bleeding (27.1% vs. 38.8%, P = 0.04) and underwent transfusion of packed red blood cells of ≤3 units (25.7% vs. 43.3%, P = 0.002). Median hospital stay was shorter in the percutaneous group (3 days vs. 4 days, P = 0.002). CONCLUSIONS: The percutaneous approach is a feasible access/closure method with a potential of lowering access site infection and bleeding, and shortening hospital stay, while maintaining similar rates of major vascular complications compared to the surgical approach.
Authors: Suzanne M Vrancken; Boudewijn L S Borger van der Burg; Paul J E M Vrancken; Gert-Aldert H Kock; Todd E Rasmussen; Rigo Hoencamp Journal: Eur J Trauma Emerg Surg Date: 2020-05-29 Impact factor: 3.693
Authors: Wayne Batchelor; Krishna Patel; Julian Hurt; James Totten; Penny Burroughs; Ginny Smith; Mig Cuervo; Lakerria Davis; Abdulla A Damluji; Kelly Epps; Matthew Sherwood; Scott Barnett; Nadim Geloo; Shahram Yazdani; Eric Sarin; Liam Ryan; Thomas Noel Journal: Cardiovasc Revasc Med Date: 2020-01-15
Authors: Vinayak Kumar; Gurpreet S Sandhu; Charles M Harper; Henry H Ting; Charanjit S Rihal Journal: J Am Heart Assoc Date: 2020-04-17 Impact factor: 5.501
Authors: Paul T L Chiam; Kentaro Hayashida; Yusuke Watanabe; Wei-Hsian Yin; Hsien-Li Kao; Michael K Y Lee; Fabio Enrique Posas; Mann Chandavimol; Wacin Buddhari; Timothy C Dy; Ngoc Quang Nguyen; Won Jang Kim; Kiyuk Chang; Mao-Shin Lin; Yat-Yin Lam; Hung Manh Pham; Shaiful Azmi Yahaya; Kay Woon Ho; Wenzhi Pan; Xian-Bao Liu; Jian'an Wang; Hyo Soo Kim; Mao Chen Journal: Open Heart Date: 2021-01